Copyright © Accurexa Inc. All rights reserved.
Accurexa Files Patent Application for the Combination of a PARP inhibitor with its ACX-31 Local Chemotherapy Wafer
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
Accurexa Announces Positive FDA Pre-IND Meeting Outcome for its ACX-31 Brain Cancer Program
Accurexa Files Patent Application for its ACX-31 Brain Cancer Program
View on Mobile